Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome


Clave P., Acalovschi M., Triantafillidis J. K., Uspensky Y. P., Kalayci C., Shee V., ...More

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol.34, no.4, pp.432-442, 2011 (SCI-Expanded) identifier

Abstract

Background